Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Organ donor screening practices for Trypanosoma cruzi infection among US Organ Procurement Organizations.

Schwartz BS, Paster M, Ison MG, Chin-Hong PV.

Am J Transplant. 2011 Apr;11(4):848-51. doi: 10.1111/j.1600-6143.2011.03436.x. Epub 2011 Mar 22.

2.

Strategies for prevention of transfusion-associated Chagas' disease.

Moraes-Souza H, Bordin JO.

Transfus Med Rev. 1996 Jul;10(3):161-70. Review.

PMID:
8809967
3.

Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity.

Kaul DR, Taranto S, Alexander C, Covington S, Marvin M, Nowicki M, Orlowski J, Pancoska C, Pruett TL, Ison MG; HTLV Donor Screening Advisory Group.

Am J Transplant. 2010 Feb;10(2):207-13. doi: 10.1111/j.1600-6143.2009.02867.x. Epub 2009 Oct 15. Review.

4.

Expanding the donor pool: use of marginal donors for solid organ transplantation.

Alexander JW, Zola JC.

Clin Transplant. 1996 Feb;10(1 Pt 1):1-19. Review.

PMID:
8652891
5.

Seropositivity for anti-trypanosoma cruzi antibodies among blood donors of the "Hospital Universitário Regional do Norte do Paraná", Londrina, Brazil.

Reiche EM, Inouye MM, Pontello R, Morimoto HK, Itow Jankevicius S, Matsuo T, Jankevicius JV.

Rev Inst Med Trop Sao Paulo. 1996 May-Jun;38(3):233-40. Review.

PMID:
9163992
6.

Chagas disease and the US blood supply.

Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL.

Curr Opin Infect Dis. 2008 Oct;21(5):476-82. doi: 10.1097/QCO.0b013e32830ef5b6. Review.

PMID:
18725796
7.

Prevention of transfusional Trypanosoma cruzi infection in Latin America.

Schmunis GA.

Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:93-101. Review.

8.

Chagas disease in the immunosuppressed host.

Bern C.

Curr Opin Infect Dis. 2012 Aug;25(4):450-7. doi: 10.1097/QCO.0b013e328354f179. Review.

PMID:
22614520
9.

Chagas disease in solid organ and heart transplantation.

Kransdorf EP, Zakowski PC, Kobashigawa JA.

Curr Opin Infect Dis. 2014 Oct;27(5):418-24. doi: 10.1097/QCO.0000000000000088. Review.

PMID:
25023742
10.

Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas.

Pinazo MJ, Miranda B, Rodríguez-Villar C, Altclas J, Brunet Serra M, García-Otero EC, de Almeida EA, de la Mata García M, Gascon J, García Rodríguez M, Manito N, Moreno Camacho A, Oppenheimer F, Puente Puente S, Riarte A, Salas Coronas J, Salavert Lletí M, Sanz GF, Torrico F, Torrús Tendero D, Ussetti P, Shikanai-Yasuda MA.

Transplant Rev (Orlando). 2011 Jul;25(3):91-101. doi: 10.1016/j.trre.2010.12.002. Epub 2011 Apr 29. Review.

PMID:
21530219
11.

HTLV-1 in solid-organ transplantation: current challenges and future management strategies.

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM.

Transplantation. 2012 Dec 15;94(11):1075-84. doi: 10.1097/TP.0b013e318263ad7a. Review.

PMID:
23060278
12.

New technologies for infectious screening of organ donors.

Fishman JA.

Transplant Proc. 2011 Jul-Aug;43(6):2443-5. doi: 10.1016/j.transproceed.2011.06.019. Review.

PMID:
21839288
13.

Transplant tourism and donor-derived parasitic infections.

Kotton CN.

Transplant Proc. 2011 Jul-Aug;43(6):2448-9. doi: 10.1016/j.transproceed.2011.06.022. Review.

PMID:
21839290
14.

An update on donor-derived disease transmission in organ transplantation.

Ison MG, Nalesnik MA.

Am J Transplant. 2011 Jun;11(6):1123-30. doi: 10.1111/j.1600-6143.2011.03493.x. Epub 2011 Mar 28. Review.

15.

Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation.

Len Ó, Ramos A, Pahissa A.

Enferm Infecc Microbiol Clin. 2012 Mar;30 Suppl 2:19-26. doi: 10.1016/S0213-005X(12)70078-2. Review.

PMID:
22542031
16.

Screening of living organ donors for endemic infections: Understanding the challenges and benefits of enhanced screening.

Rosen A, Ison MG.

Transpl Infect Dis. 2016 Nov 14. doi: 10.1111/tid.12633. [Epub ahead of print] Review.

PMID:
27862705
17.

Challenges to research and innovation to optimize deceased donor organ quality and quantity.

Abt PL, Marsh CL, Dunn TB, Hewitt WR, Rodrigue JR, Ham JM, Feng S.

Am J Transplant. 2013 Jun;13(6):1400-4. doi: 10.1111/ajt.12243. Epub 2013 Apr 25. Review.

18.

Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report.

Morris MI, Daly JS, Blumberg E, Kumar D, Sester M, Schluger N, Kim SH, Schwartz BS, Ison MG, Humar A, Singh N, Michaels M, Orlowski JP, Delmonico F, Pruett T, John GT, Kotton CN.

Am J Transplant. 2012 Sep;12(9):2288-300. doi: 10.1111/j.1600-6143.2012.04205.x. Epub 2012 Aug 6. Erratum in: Am J Transplant. 2013 Feb;13(2):528.

19.

Procurement strategies for combined multiorgan and composite tissues for transplantation.

Datta N, Yersiz H, Kaldas F, Azari K.

Curr Opin Organ Transplant. 2015 Apr;20(2):121-6. doi: 10.1097/MOT.0000000000000172. Review.

PMID:
25856175
20.

A simple bedside approach to therapeutic goals achievement during the management of deceased organ donors--An adapted version of the "VIP" approach.

Westphal GA.

Clin Transplant. 2016 Feb;30(2):138-44. doi: 10.1111/ctr.12667. Epub 2016 Jan 8. Review.

PMID:
26588881

Supplemental Content

Support Center